An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

NCT00002142 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Cidofovir
DRUG: Probenecid

Sponsor

Gilead Sciences